Martine Walmsley's Avatar

Martine Walmsley

@f8martine.bsky.social

PSC | Coeliac | IBD | Patient Advocate Involve patients in your research! Head of Research Strategy PSC Support😁 she/her

130 Followers  |  51 Following  |  1 Posts  |  Joined: 09.01.2025  |  1.5512

Latest posts by f8martine.bsky.social on Bluesky

We welcome this important research from @icrlondon.bsky.social & St Mark's Hospital. They've found a way to predict #BowelCancer risk in people with #InflammatoryBowelDisease.

This could help guide treatment & colonoscopy frequency and may lead to more personalised care for those with #PSC-IBD

07.02.2025 12:07 — 👍 2    🔁 2    💬 0    📌 0
Post image

Starting to come up with ideas for #20kyourway #pscsupport #LiverSky #PSC

30.12.2024 16:17 — 👍 1    🔁 1    💬 0    📌 0

🎆Research granted🎆

Grants always carry a sense of responsibility, but receiving one from a patient organization takes this to a whole new level

PSC Support decided to support our project Multiomics data for personalised PSC prognosis

#PSCSupport #AI
#Personnalised_medicine #Hepatology

20.01.2025 08:17 — 👍 4    🔁 1    💬 0    📌 0
Video thumbnail

2025 is the perfect year to take your career to the next level🚀

There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force.

Apply by 20 January: easl.eu/leadership25

#LiverSky

15.01.2025 09:34 — 👍 12    🔁 5    💬 0    📌 0

Welcome to BlueSky Martine Walmsley, Head of Research Strategy PSC Support @f8martine.bsky.social.

Check out our growing PSC Starter Pack (I've added you!) go.bsky.app/6hLJsJT Please suggest any new PSC people to add.

#PSC

10.01.2025 16:40 — 👍 4    🔁 1    💬 1    📌 0

Thanks @katecoldwell.bsky.social Great Starter Pack! I'll tag some people here over the weekend!

10.01.2025 16:56 — 👍 1    🔁 0    💬 0    📌 0
Preview
Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures AbstractBackground. We conducted a single-arm interventional study, to explore mucosal changes associated with clinical remission under oral vancomycin (OV

New work from us:
Oral vancomycin is associated with attenuation in IBD activity in people with PSC. We also studied changes in gut microbiome profile, and key transcriptomic and metabolomic features.

academic.oup.com/ecco-jcc/adv...

14.12.2024 13:18 — 👍 6    🔁 2    💬 0    📌 0
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven...

Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social

07.01.2025 07:30 — 👍 23    🔁 10    💬 1    📌 2

@f8martine is following 19 prominent accounts